Poster Session II. - G: Pharmaceutical Sciences and Health Technologies
Mr. Váczy-Földi Máté, MSc
XA6S0Q
Institute of Pharmacology and Pharmacotherapy
+36205047462
vaczy.foldi.mate@semmelweis.hu
Predicting MicroRNA Effects with Consideration for RNA-Binding Proteins
Máté Váczy-Földi1, Eszter Balogh1, Zsolt Tamás Papp1, Bettina Benczik1, Péter Ferdinandy1, Péter Bencsik2, Bence Ágg1
1: Cardiometabolic and HUN-REN-SU System Pharmacology Research Group, Department of Pharmacology and Pharmacotherapy, Center for Pharmacology and Drug Research & Development, Semmelweis University, Budapest, Hungary
2: Pharmahungary Group, Szeged, Hungary
Poszter
Poster Session II. - G: Pharmaceutical Sciences and Health Technologies
English
Pharmaceutical Sciences and Health Technologies
Introduction
MicroRNAs (miRNAs) which are ~22 nucleotides long double-stranded non-coding RNAs regulate gene expression by binding to messenger RNAs (mRNAs) via their seed region, causing mRNA destabilization, degradation, or translational repression. However, miRNA gene expression regulation is complemented by RNA-binding proteins (RBPs) which modulate miRNA function. Therefore, including the impact of RBPs in the modelling of miRNA effect could greatly improve the precision of prediction.
Aims
We aimed to develop a miRNA effect prediction model based on a network dynamics algorithm which accounts for the modulation of miRNA function by RBPs.
Method
Our miRNA effect prediction model first constructs a network of miRNAs, mRNAs, RBPs, and their binding sites. MiRNA-mRNA interactions are identified using the miRanda software, and RBP-mRNA interactions with a Position Weight Matrix approach. MiRNA nodes and RBP nodes are then initialized with differential expression data, and theoretical values respectively. Finally, these values are propagated across the network using the propagation version of the Dynamics-Agnostic Network Models algorithm to predict mRNA values, from which relative miRNA effects could be inferred.
Results
We have completed the model implementation incorporating two RBPs, ELAVL1 and PUM2, and identified 855 495 ELAVL1 and 157 530 PUM2 binding site in the human 3’-UTR regions using a literature-based threshold. The model was applied to 3 test datasets containing 20 individual comparisons.
Conclusion
We present a novel, network-dynamics approach to miRNA effect prediction which integrates the influence of RBPs. Future work will focus on evaluation of the model against established, state of the art, prediction tools.
Funding
The 2020-1.1.5-GYORSÍTÓSÁV-2021-00011 project was funded by the Ministry for Innovation and Technology with support from the National Research Development and Innovation Fund under the 2020-1.1.5-GYORSÍTÓSÁV call programme. Project no. RRF-2.3.1-21-2022-00003 has been implemented with the support provided by the European Union. Supported by the 2024-2.1.2-EKÖP-KDP New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund. This study has been supported by a Semmelweis 250+ Excellence Fellowship.
Semmelweis University
Bence Ágg MD, PhD
I do not give consent to the publication of my abstract on the website of the congress.
in doctoral studies before complex exam (PhD)
Szabad
elfogadva
poszter
nem rendelkezett róla
9071
18:06
18:12